What Your Blood Can Actually Tell You
The thing that separates one longevity test from the next isn't how many markers it returns—it's which molecules it can see, and how carefully it reads them together. Here's what that depth actually looks like.
Two blood tests can both promise to "optimize your longevity" and measure almost entirely different things. One reports a familiar set of numbers—cholesterol, glucose, a metabolic panel—from assays available at any standard lab. Another reads thousands of small molecules at once, including whole classes of lipids that never appear on a conventional menu, and weighs each result against the others to make sense of it. Same promise; very different picture.
So the useful question isn't how many markers a test counts. It's how deeply it can read your biochemistry—and whether it can tell you what those readings mean together. That is the ground where broad metabolomic and lipidomic profiling lives, and it's worth understanding what that depth actually buys you.1
01Three approaches, three different questions
Most longevity tests fall into one of three families. Each is useful, and each answers a genuinely different question.
A large set of conventional markers—lipids, glucose, hormones, blood counts—run on the same assays used by standard labs.
"Are my usual numbers in range?"
Your data condensed into a single figure for how "old" your biology looks. A memorable headline—but a headline, not the chemistry beneath it.
"How fast am I aging?"
Thousands of small molecules read at once—including membrane lipids that aren't on the standard menu—and interpreted as a connected picture.
"What is my biology actually doing?"
Standard panels check conventional numbers; biological-age tests return a single score; metabolomic and lipidomic profiling maps the underlying chemistry and reads it as a whole. The depth and the interpretation are what set the third apart.
02What it means to read your chemistry
There's a reason the metabolome is so revealing. Your genes set out instructions; your proteins carry them out; metabolites are largely the result—the molecules produced and left behind as all of that activity happens. That makes the metabolome the layer of biology closest to your actual physiology, a functional readout of what your body is doing right now rather than what it was built to do.1 And modern profiling can survey a remarkable span of that chemistry—thousands of small molecules at once, from a single small sample.2
But breadth alone isn't the point—a long list of molecules is just noise without a map. Decades of this research keep returning to four systems that, between them, shape most of how the body functions and ages. They're easy to remember as the four M's.
The physical structure of every cell and the place where cellular activity begins. Their composition shapes how cells work.
Your energy system—a living battery that turns fuel into usable power. When supply can't meet demand, you feel it.
The build-and-maintain system for membranes, muscle, and key signaling molecules. Quiet, constant, easy to misread.
Far more than movement—a central regulator of metabolic health, and a system you can read through the blood.
Metabolites are the functional result of your biology in action, so a broad profile reads the layer closest to how you're working. Organized around four systems—membranes, mitochondria, methylation, muscle—that breadth becomes something you can actually interpret.
03Membranes: the layer standard panels never reach
Start with membranes, because they're where the most distinctive molecules live. A membrane isn't a passive wall. It's the active surface where cellular life happens—the reason your body is organized tissue and not, as the science is fond of putting it, a bowl of soup. When a neuron fires, one membrane releases a signal and the next receives it. So the composition of your membranes helps set how well your cells do their jobs, which is why membrane changes are among the most reliable molecular signals of how the body ages.
Living in those membranes is a class of lipids called plasmalogens. Their signature is an unusual chemical link—a vinyl-ether bond—and they come in two main families (ethanolamine and choline forms). They're especially abundant in tissues with high demands like the brain and heart, and research suggests that same reactive bond may let them protect neighboring molecules from oxidative damage, a kind of built-in antioxidant within the membrane.45 Their levels also tend to change with age.4 None of this shows up on a standard panel—there simply isn't a routine assay for it.
And how a molecule is read matters as much as whether it's read at all. Take omega-3. A typical test digests the sample down to free fatty acids and reports a single total—blending what came from storage fats with what came from your cell membranes. Read instead on the intact phospholipid, omega-3 becomes a direct look at membrane composition rather than a pooled average.3 Same word, very different information.
Sources are pooled, so membrane and storage fats blur into a single value.
Measured in place, so you see actual membrane composition (in red).
Membranes are active surfaces, and their composition shapes how cells function. Plasmalogens—distinctive membrane lipids absent from standard panels—are a window into that layer, and reading lipids on the intact molecule gives a direct view of membrane composition rather than a blended total.
04Why one number can mislead
Depth isn't only about exotic molecules. It's also about reading ordinary markers in context—because the same value can mean opposite things depending on the chemistry around it. Two everyday examples make the point.
Homocysteine. It's often treated as "lower is always better." But homocysteine isn't a toxin to be minimized—it's a readout of how much methylation work your body is doing, and methylation is the system that builds and maintains your membranes, muscle, and signaling molecules. Push the number very low and it may simply mean that building work has slowed. It can also be masked: certain nutrients recycle homocysteine behind the scenes, so a tidy-looking value can sit on top of a system that isn't actually keeping up. The number alone can't tell you which story is true—the surrounding markers can.
Creatinine. With healthy kidneys, a moderately high level can reflect good muscle mass, while a low level can hint at muscle loss. Change the kidney context and that very same number means something else entirely. Read in isolation, it's ambiguous; read alongside kidney and muscle markers, it becomes informative.
A biomarker is only as good as the story around it.
This is what a connected profile does that a lone value or a single score can't: it reads each result in the company of the others, so a number's meaning is interpreted rather than assumed.
The same marker can carry opposite meanings depending on context—homocysteine and creatinine both flip with the chemistry around them. Reading many systems together lets a result be interpreted accurately instead of taken at face value.
05Built to be followed, not filed away
A profile this detailed is meant to be lived with, not glanced at once. Because the metabolome shifts in real time with your diet, sleep, movement, and stress, its most valuable comparison is you to you, over time: establish a clear baseline, support your biology with the fundamentals and the guidance of a qualified healthcare professional, then re-measure to see what actually moved.
Baseline
Establish where your biochemistry sits today.
Support
Work the fundamentals with your professional.
Re-measure
See what moved—against your own starting point.
A snapshot is filed away; a baseline is followed. Because the metabolome changes day to day, the value is tracking yourself over time—watching the specific chemistry shift, not re-reading a single number.
06What this can—and can't—tell you
Honesty matters here. A broad metabolomic or lipidomic profile is powerful, but it is not a diagnostic test. It does not name a condition, and any single snapshot can be nudged by ordinary things—what you ate, how you slept, the time of day. That variability is the case for reading it carefully and over time, not against it.
Its job is to give you an objective, detailed baseline you can understand and follow—a starting point, not a verdict. The most important partner in making sense of any result is a qualified healthcare professional who knows your history and can place the numbers in the context of your whole health.
A profile is a baseline, not a diagnosis. It maps your chemistry for you to understand and follow over time—best interpreted alongside the fundamentals and a qualified healthcare professional.
Frequently asked questions
What does a metabolomic and lipidomic profile actually measure?
Thousands of small molecules at once, including membrane lipids like plasmalogens that aren't part of standard panels—organized around the systems that shape how the body functions and ages: membranes, mitochondria, methylation, and muscle.14
Why can't I just add these markers to a standard panel?
For molecules like plasmalogens there isn't a routine assay—and reading a fatty acid on the intact phospholipid, rather than as a digested total, requires the profiling approach itself. It's a different way of measuring, not a longer checklist.34
Is this the same as a biological-age test?
No. A biological-age test returns a single score—an estimate of how fast you're aging. A profile gives you the underlying chemistry behind that picture, which you can understand and track over time.
Can a metabolomic profile diagnose anything?
No. It's an educational and research tool for establishing a biochemical baseline. It is not designed to diagnose, treat, cure, or prevent anything—that's the role of a qualified healthcare professional.
Depth, then context, then time. Reading molecules a standard panel can't—and weighing each one against the others—gives you something a single number never will: an honest picture of how your biology is working today, and a baseline you can follow tomorrow.
Curious what a fuller picture looks like?
BioAssess™ uses ProdromeScan™ and PlasmalogenScan™—and, for the most comprehensive profile, the BioScan™—to help establish and track your personal biochemical baseline for educational and research purposes.
Explore BioAssess™The editorial team translates the science behind Dr. Goodenowe Perpetual Health into clear, accurate explainers for a general audience.
This explainer draws on the metabolomics and lipidomics research of Dr. Dayan Goodenowe—a neuroscientist and biochemist (PhD, Medical Science, 1993) who, in 1999, invented the ion cyclotron resonance mass spectrometry technology behind comprehensive biochemical profiling. He is a research scientist and educator, not a licensed physician.
References
- Fiehn, O. (2002). Metabolomics – the link between genotypes and phenotypes. Plant Molecular Biology, 48(1–2), 155–171. https://doi.org/10.1023/A:1013713905833
- Newgard, C. B. (2017). Metabolomics and metabolic diseases: where do we stand? Cell Metabolism, 25(1), 43–56. https://doi.org/10.1016/j.cmet.2016.09.018
- Yang, K., & Han, X. (2016). Lipidomics: techniques, applications, and outcomes related to biomedical sciences. Trends in Biochemical Sciences, 41(11), 954–969. https://doi.org/10.1016/j.tibs.2016.08.010
- Paul, S., Lancaster, G. I., & Meikle, P. J. (2019). Plasmalogens: a potential therapeutic target for neurodegenerative and cardiometabolic disease. Progress in Lipid Research, 74, 186–195. https://doi.org/10.1016/j.plipres.2019.04.003
- Brites, P., Waterham, H. R., & Wanders, R. J. A. (2004). Functions and biosynthesis of plasmalogens in health and disease. Biochimica et Biophysica Acta (BBA) – Molecular and Cell Biology of Lipids, 1636(2–3), 219–231. https://doi.org/10.1016/j.bbalip.2003.12.010
Dr. Goodenowe Perpetual Health operates as a self-directed research model and is not a medical facility. The information provided here is for educational and research purposes only and is not intended to diagnose, treat, cure, or prevent any disease or medical condition.
Participation is voluntary, and individuals assume full responsibility for their own health and well-being. Always consult a qualified healthcare professional regarding your individual health needs and before making changes to your health routine. Results are not guaranteed and will vary from person to person.
These statements have not been evaluated by the Food and Drug Administration. BioScan™, ProdromeScan™, PlasmalogenScan™, BioAssess™, and any related products or services are not intended to diagnose, treat, cure, or prevent any disease.
Share:
Metabolomics 101
Plasmalogens 101